SP4 and juvenile dermatomyositis: Anti-CCAR1 autoantibody frequency was 9% of an anti-TIF1γ positive US juvenile dermatomyositis (JDM) cohort screened by ELISA, and was associated with a lower frequency of cutaneous ulceration and similar clinical features to anti-Sp4 autoantibodies [12].